Nareru Group Inc.
Nareru Group Inc. (9163.T) Financial Performance & Income Statement Overview
Review Nareru Group Inc. (9163.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Nareru Group Inc. (9163.T) Income Statement & Financial Overview
Explore comprehensive income reports for Nareru Group Inc. 9163.T, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.89B | $5.81B | $5.60B | $5.22B |
| Cost of Revenue | $4.28B | $4.19B | $4.06B | $3.91B |
| Gross Profit | $1.62B | $1.62B | $1.54B | $1.30B |
| Gross Profit Ratio | $0.27 | $0.28 | $0.28 | $0.25 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $717.79M | $665.00M | $731.05M | $718.45M |
| Operating Expenses | $717.79M | $665.00M | $728.003M | $714.12M |
| Total Costs & Expenses | $4.99B | -$4.85B | $4.78B | $4.63B |
| Interest Income | $0.00 | $357000.00 | $0.00 | $535000.00 |
| Interest Expense | $16.74M | $14.97M | $0.00 | $11.44M |
| Depreciation & Amortization | $73.14M | $64.91M | $65.82M | $65.32M |
| EBITDA | $973.54M | $1.03B | $881.50M | $654.85M |
| EBITDA Ratio | $0.17 | $0.18 | $0.16 | $0.13 |
| Operating Income | $897.50M | $953.84M | $815.68M | $589.00M |
| Operating Income Ratio | $0.15 | $0.16 | $0.15 | $0.11 |
| Other Income/Expenses (Net) | -$13.85M | -$6.62M | -$13.99M | -$10.90M |
| Income Before Tax | $883.66M | $947.21M | $801.68M | $578.10M |
| Income Before Tax Ratio | $0.15 | $0.16 | $0.14 | $0.11 |
| Income Tax Expense | $233.68M | $248.26M | $236.61M | $170.62M |
| Net Income | $649.98M | $698.96M | $565.07M | $407.47M |
| Net Income Ratio | $0.11 | $0.12 | $0.10 | $0.08 |
| EPS | $74.50 | $80.45 | $65.65 | $47.63 |
| Diluted EPS | $74.05 | $79.81 | $64.64 | $46.64 |
| Weighted Avg Shares Outstanding | $8.73M | $8.69M | $8.61M | $8.56M |
| Weighted Avg Shares Outstanding (Diluted) | $8.78M | $8.76M | $8.74M | $8.74M |
Over the past four quarters, Nareru Group Inc. demonstrated steady revenue growth, increasing from $5.22B in Q2 2024 to $5.89B in Q1 2025. Operating income reached $897.50M in Q1 2025, maintaining a consistent 15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $973.54M, reflecting operational efficiency. Net income dropped to $649.98M, with EPS at $74.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan